When Common Sense Leaves the Building
June 23, 2026
In this market, anything can happen, especially now that common sense appears to have packed its bags, sold the furniture, and quietly left town. Take SpaceX. It has all the markings of a modern-day Roaring Twenties story. Musk throws out profit targets that would have been laughed out of the room not long ago, yet the crowd embraces them with remarkable enthusiasm.
From an observer’s perspective, the fascinating part is not SpaceX itself. It is the reaction. Human nature never really changes. The faces change. The technology changes. The slogans change. The process remains largely the same. In real time, people volunteer to become the fall guy while convincing themselves they are acting with extraordinary intelligence.
History is littered with examples of this behavior. Every great speculative period develops its own language, its own heroes, and its own explanations for why traditional measures no longer apply. The story is always different. The psychology rarely is.
A Rare Case of Industrial Logic
Against that backdrop, the Olin-Huntsman transaction feels almost strange because it actually makes sense.
The market’s mixed reaction is therefore somewhat ironic. The only reasonable conclusion is that both sides see meaningful long-term value and view this as something closer to a survival move than a financial exercise.
The unusual pricing structure reinforces that view. Rather than relying on the previous day’s stock price, the companies chose a 30-day volume-weighted average price formula, arguing that it provides a fairer long-term valuation. In theory they are correct. In practice, shareholders have always preferred cash premiums to theoretical fairness.
Viewed through the lens of industrial logic, the transaction is straightforward. Olin produces key chemical feedstocks such as chlorine and caustic soda, while Huntsman converts those inputs into higher-value specialty chemicals and polyurethanes. One company produces the ingredients. The other transforms them into products customers actually use.
The merger creates a more vertically integrated operation, reduces dependence on outside suppliers, improves efficiency, and potentially generates more than $400 million in annual synergies if management’s projections prove accurate.
Theory and Execution Live in Different Neighborhoods
The challenge, as always, is that theory and execution have never lived in the same neighborhood.
Markets often assume that spreadsheets automatically become reality. Anyone who has watched enough mergers knows otherwise. Synergies are easy to announce and considerably harder to achieve. Cultures clash. Systems refuse to cooperate. Customers behave differently than expected. What appears elegant on paper frequently becomes messy in practice.
Still, the timing is difficult to criticize. The chemical sector remains trapped in a difficult part of the cycle. Demand is uneven, margins remain under pressure, and investor enthusiasm has migrated elsewhere. Combining businesses near the lower end of a cycle has historically produced better outcomes than attempting the same feat near a peak.
One could easily make the opposite argument from a Huntsman shareholder’s perspective. Shareholders could have sold stock at prevailing market prices and retained flexibility. Why exchange certainty for future promises? It is a fair question.
Ultimately, management now owns the burden of proof. If the efficiencies materialize, the deal may look brilliant several years from now. If they fail to materialize, shareholders will conclude they exchanged certainty for hope.
The Story We Are Watching Closely
That brings us to a completely different situation, though one that shares a similar characteristic.
The market is currently focused on risk while quietly ignoring potential asymmetry.
We have been monitoring a biotech company whose trial data continues to improve with each update. The company remains highly speculative and FDA approval is far from guaranteed. In biotechnology, certainty is usually expensive and often dangerous.
What makes the story interesting is not that success is guaranteed. It is that the market appears far more focused on what can go wrong than on what happens if things go right.
That is often where the largest opportunities emerge.
The crowd naturally gravitates toward certainty. It prefers established winners, familiar narratives, and outcomes that already feel obvious. By the time certainty arrives, most of the reward has usually disappeared.
The real opportunities tend to appear when the facts are visible but the implications remain poorly understood.
That is why we continue watching.
The market sees risk.
We see a developing story.
Those are not always the same thing.
